The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Open accessAbstract
IMPORTANCE: Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE: To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS: The Centers for Disease Control and Prevention (CDC) updated a 2014 systematic review on effectiveness and risks of opioids and conducted a supplemental review on benefits and harms, values and preferences, and costs. CDC used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess evidence type and determine the recommendation category. EVIDENCE SYNTHESIS: Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology. Meta-analysis was not attempted due to the limited number of studies, variability in study designs and clinical heterogeneity, and methodological shortcomings of studies. No study evaluated long-term (≥1 year) benefit of opioids for chronic pain. Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent effects. RECOMMENDATIONS: There are 12 recommendations. Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks. Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks. When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day, and avoid concurrent opioids and benzodiazepines whenever possible. Clinicians should evaluate benefits and harms of continued opioid therapy with patients every 3 months or more frequently and review prescription drug monitoring program data, when available, for high-risk combinations or dosages. For patients with opioid use disorder, clinicians should offer or arrange evidence-based treatment, such as medication-assisted treatment with buprenorphine or methadone. CONCLUSIONS AND RELEVANCE: The guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
17 Own result · 3 Not checked yet · 2 Own method · 2 No basis given · 1 Sources not found
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day,”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Several nonpharmacologic and nonopioid pharmacologic treatments were found to be effective for chronic pain in studies ranging in duration from 2 weeks to 6 months48–66 (Table 3).”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Contextual Evidence Review
What the sources say
- Not matchedcites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated long-term (≥1 year) benefit of opioids for chronic pain.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recommendations in the guideline are voluntary, rather than prescriptive standards. They are based on emerging evidence, including observational studies or randomized clinical trials with notable limitations.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > CONCLUSIONS AND RELEVANCE
None of the sources cited for this claim have been checked yet.
In the paper
“Studies examining patients who underwent low-risk surgery or experienced low back pain from injury revealed that opioid therapy prescribed for acute pain was associated with greater likelihood of long-term use.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
What the sources say
- Not checked yetcites [46]
- Not checked yetcites [47]
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated the effectiveness of risk mitigation strategies.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent affects.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A study of almost 100,000 patients found that the average rate of tapering was 34.0% of the original dose per month and more than a quarter of patients were tapering at a rate faster than 40% of their original dose per month,43,49 even higher than the maximum rate recommended by the CDC. 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, opioids are significantly less effective against chronic pain, such as neuropathic pain, fibromyalgia, and low-back pain, and tolerance develops to the analgesic effects of opioids, thus necessitating the need for increasingly higher doses to sustain analgesia (McQuay, 1988;Dowell et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Dowell et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The influential Centres for Disease Control (CDC) Guideline for Prescribing Opioids recommends a linear reduction of opioid doses: ‘A decrease of 10% of the original dose per week’ or ‘slower tapers (e.g. 10% per month)’ for longer term users (Figure 1(a)). 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
In the citing paper
“Opioids are also associated with substantial systemic harm such as worsening psychopathology, addiction, tolerance, and premature death. 24”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [24]
In the citing paper
“The Centers for Disease Control and Prevention and US Food and Drug Administration issued warnings in 2016 to make prescribers and patients aware of these risks.19,34”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [34]
In the citing paper
“evidence of their longterm efficacy and safety is limited.6”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
In the citing paper
“Although opioids are considered to be useful in managing a wide continuum of pain, including acute, procedural, and chronic pain”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Self-citationPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Cited by
Sorted by citations
Items 201–300 of 1,036
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability
Cooper, Z. D., Bedi, G., Ramesh, D., Balter, R. E., Comer, S. D., & Haney, M. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0011-2 · Cited by 147
Diagnosis and management of low-back pain in primary care
Traeger, A. C., Buchbinder, R., Harris, I. A., & Maher, C. G. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170527 · Cited by 153
Henningfield, J. E., Fant, R. V., & Wang, D. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4813-4 · Cited by 151
Addressing the Opioid Epidemic: Is There a Role for Physician Education?
Schnell, M. K., & Currie, J. (2017) · American Journal of Health Economics · doi:10.1162/ajhe_a_00113 · Cited by 142
Current Issues in the Use of Opioids for the Management of Postoperative Pain
Macintyre, P. E., Quinlan, J., Levy, N., & Lobo, D. N. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.6210 · Cited by 140
Ju, C., Wei, L., Man, K. K. C., Wang, Z., Ma, T.-T., Chan, A., Brauer, R., Chui, C., Chan, E., Jani, Y. H., et al. (2022) · Lancet Public Health · doi:10.1016/s2468-2667(22)00013-5 · Cited by 119
“With the increased awareness of opioid misuse, 7,23,24 a combination of strategies, including opioid prescribing guidelines and laws, the prescription drug monitoring programmes, and professional and public education programmes were introduced in the USA to reduce inappropriate opioid prescribing.”
The opioid crisis: Origins, trends, policies, and the roles of pharmacists
Chisholm‐Burns, M. A., Spivey, C. A., Sherwin, E., Wheeler, J. S., & Hohmeier, K. C. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxy089 · Cited by 147
The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain
Aziz, Q., Giamberardino, M. A., Barke, A., Korwisi, B., Baranowski, A. P., Wesselmann, U., Rief, W., Treede, R., & Pain, T. I. T. F. T. C. O. C. (2018) · Pain · doi:10.1097/j.pain.0000000000001362 · Cited by 161
Kazis, L. E., Ameli, O., Rothendler, J. A., Garrity, B. M., Cabral, H., McDonough, C. M., Carey, K., Stein, M. D., Sanghavi, D. M., Elton, D., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028633 · Cited by 143
Eidson, L. N., Inoue, K., Young, L. J., Tansey, M. G., & Murphy, A. Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.131 · Cited by 140
Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care
Liebschutz, J. M., Xuan, Z., Shanahan, C. W., Larochelle, M. R., Keosaian, J. E., Beers, D., Guara, G., O’Connor, K., Alford, D. P., Parker, V. A., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2468 · Cited by 142
Boehnke, K. F., Scott, J. R., Litinas, E., Sisley, S., Williams, D. A., & Clauw, D. J. (2019) · Journal of Pain · doi:10.1016/j.jpain.2019.01.010 · Cited by 139
State-level lifetime medical and work-loss costs of fatal injuries—United States, 2014.
Luo, F., & Florence, C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6601a1 · Cited by 136
Associations Between Adolescent Chronic Pain and Prescription Opioid Misuse in Adulthood
Groenewald, C. B., Law, E. F., Fisher, E., Beals‐Erickson, S. E., & Palermo, T. M. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.07.007 · Cited by 143
America’s opioid crisis: the need for an integrated public health approach
Blanco, C., Wiley, T., Lloyd, J. J., Lopez, M. F., & Volkow, N. D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0847-1 · Cited by 144
State legal innovations to encourage naloxone dispensing
Davis, C. S., & Carr, D. H. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.007 · Cited by 135
2017 update on pain management in patients with chronic kidney disease
Pham, P. C., Khaing, K., Sievers, T. M., Pham, P. M., Miller, J. M., Pham, S. V., Pham, P. A., & Pham, P. T. T. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx080 · Cited by 137
Dunn, L. K., Yerra, S., Fang, S., Hanak, M. F., Leibowitz, M. K., Tsang, S., Durieux, M. E., Nemergut, E. C., & Naik, B. I. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003338 · Cited by 135
Dailey, D. L., Vance, C. G. T., Rakel, B. A., Zimmerman, M. B., Embree, J. L., Merriwether, E. N., Geasland, K. M., Chimenti, R. L., Williams, J. M., Golchha, M., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41170 · Cited by 143
Petrosky, E., Harpaz, R., Fowler, K. A., Bohm, M. K., Helmick, C. G., Yuan, K., & Betz, C. J. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0830 · Cited by 134
Chiu, A. S., Healy, J. M., DeWane, M. P., Longo, W. E., & Yoo, P. S. (2017) · Journal of surgical education · doi:10.1016/j.jsurg.2017.06.020 · Cited by 135
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages
Haffajee, R. L., Mello, M. M., Zhang, F., Zaslavsky, A. M., Larochelle, M. R., & Wharam, J. F. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1321 · Cited by 135
Winhusen, T. M., Walley, A. Y., Fanucchi, L. C., Hunt, T., Lyons, M., Lofwall, M. R., Brown, J. L., Freeman, P. R., Nunes, E. V., Beers, D., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108325 · Cited by 135
Primary care physicians’ perspectives on the prescription opioid epidemic
Kennedy‐Hendricks, A., Busch, S. H., McGinty, E. E., Bachhuber, M. A., Niederdeppe, J., Gollust, S. E., Webster, D. W., Fiellin, D. A., & Barry, C. L. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.05.010 · Cited by 139
Opioid Use Disorders: Perioperative Management of a Special Population
Ward, E. N., Quaye, A., & Wilens, T. E. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003477 · Cited by 136
Xiang, H., Shen, J., Wheeler, K. K., Patterson, J., Lever, K., Armstrong, M., Shi, J., Thakkar, R. K., Groner, J. I., Noffsinger, D. L., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.12082 · Cited by 132
Educational Disabilities Among Children Born With Neonatal Abstinence Syndrome
Fill, M. A., Miller, A. M., Wilkinson, R. H., Warren, M. D., Dunn, J. R., Schaffner, W., & Jones, T. F. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0562 · Cited by 140
Soffin, E. M., Vaishnav, A. S., Wetmore, D. S., Barber, L. A., Hill, P. S., Gang, C. H., Beckman, J. D., Albert, T. J., & Qureshi, S. A. (2018) · Spine · doi:10.1097/brs.0000000000002905 · Cited by 133
Edwards, D. A., Hedrick, T. L., Jayaram, J., Argoff, C. E., Gulur, P., Holubar, S. D., Gan, T. J., Mythen, M. G., Miller, T. E., Shaw, A., et al. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004018 · Cited by 136
Head and neck cancer survivorship consensus statement from the American Head and Neck Society
Goyal, N., Day, A., Epstein, J. B., Goodman, J., Graboyes, E. M., Jalisi, S. M., Kiess, A. P., Ku, J. A., Miller, M. C., Panwar, A., et al. (2021) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.702 · Cited by 134
García, M. C., Heilig, C. M., Lee, S., Faul, M., Guy, G. P., Iademarco, M. F., Hempstead, K., Raymond, D., & Gray, J. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6802a1 · Cited by 132
Schieber, L. Z., Guy, G. P., Seth, P., & Losby, J. L. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6911a5 · Cited by 134
Kandel, D. B., Hu, M., Griesler, P. C., & Wall, M. M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.047 · Cited by 131
Empfehlungen der zweiten Aktualisierung der Leitlinie LONTS
LONTS, K. F. D. K. D. 2. A. D. S.-L., Häuser, W., Bock, F., Hüppe, M., Nothacker, M., Norda, H., Radbruch, L., Schiltenwolf, M., Schüler, M., Tölle, T. R., et al. (2020) · Der Schmerz · doi:10.1007/s00482-020-00472-y · Cited by 129
Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools
Piette, J. D., Newman, S., Krein, S. L., Marinec, N. S., Chen, J., Williams, D. A., Edmond, S. N., Driscoll, M., LaChappelle, K. M., Kerns, R. D., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.3178 · Cited by 126
Rosenberg, J. M., Bilka, B. M., Wilson, S. M., & Spevak, C. (2017) · Pain Medicine · doi:10.1093/pm/pnx203 · Cited by 128
Cheatle, M. D., Compton, P. A., Dhingra, L. K., Wasser, T., & O’Brien, C. P. (2019) · Journal of Pain · doi:10.1016/j.jpain.2019.01.011 · Cited by 126
Long‐term opioid therapy definitions and predictors: A systematic review
Karmali, R. N., Bush, C., Raman, S. R., Campbell, C. I., Skinner, A. C., & Roberts, A. W. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4929 · Cited by 131
Meisenberg, B. R., Grover, J., Campbell, C., & Korpon, D. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2908 · Cited by 126
The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse
Soffin, E. M., Lee, B. H., Kumar, K. K., & Wu, C. L. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.11.019 · Cited by 127
Singh, G. K., Kim, I. E., Girmay, M., Perry, C., Daus, G. P., Vedamuthu, I. P., Reyes, A. D. L., Ramey, C., Martin, E. K., & Allender, M. (2019) · International Journal of Maternal and Child Health and AIDS · doi:10.21106/ijma.284 · Cited by 125
Dufort, A., & Samaan, Z. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00893-z · Cited by 123
Sun, E. C., Moshfegh, J., Rishel, C. A., Cook, C. E., Goode, A. P., & George, S. Z. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.5909 · Cited by 121
Fan, A. Y., Miller, D. W., Bolash, B., Bauer, M. J., McDonald, J. L., Alemi, S. F., He, H., Li, Y. M., Matecki, A., Camardella, L., et al. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60378-9 · Cited by 123
Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use
Wen, H., Hockenberry, J. M., Jeng, P. J., & Bao, Y. (2019) · Health Affairs · doi:10.1377/hlthaff.2019.00103 · Cited by 128
Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement
Stumbo, S. P., Yarborough, B. J. H., McCarty, D. W., Weisner, C. M., & Green, C. A. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.11.003 · Cited by 120
Opioid Prescription, Morbidity, and Mortality in United States Dialysis Patients
Kimmel, P. L., Fwu, C., Abbott, K. C., Eggers, A. W., Kline, P. P., & Eggers, P. W. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010098 · Cited by 122
Using Integrative Medicine in Pain Management: An Evaluation of Current Evidence
Lin, Y., Wan, L., & Jamison, R. N. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002579 · Cited by 124
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
Szigethy, E., Knisely, M., & Drossman, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.141 · Cited by 117
Theisen, K. M., Jacobs, B. L., Macleod, L. C., & Davies, B. (2018) · British Journal of Urology · doi:10.1111/bju.14446 · Cited by 123
Häuser, W., Morlion, B. J., Vowles, K. E., Bannister, K., Buchser, E., Casale, R., Chenot, J., Chumbley, G. M., Drewes, A. M., Dom, G., et al. (2021) · European Journal of Pain · doi:10.1002/ejp.1736 · Cited by 123
Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia
Thornton, J. D., Lyvers, E., Scott, V., & Dwibedi, N. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.12.070 · Cited by 117
Battlefield acupuncture to treat low back pain in the emergency department
Fox, L. M., Murakami, M., Danesh, H., & Manini, A. F. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.02.038 · Cited by 117
Use of prescription opioids before and after an operation for chronic pain (lumbar fusion surgery)
Deyo, R. A., Hallvik, S. E., Hildebran, C., Marino, M., O’Kane, N., Carson, J., Otterloo, J. V., Wright, D. A., Millet, L. M., & Wakeland, W. W. (2018) · Pain · doi:10.1097/j.pain.0000000000001202 · Cited by 119
Wren, A., Ross, A., D’Souza, G., Almgren, C., Feinstein, A., Marshall, A., & Golianu, B. (2019) · Children · doi:10.3390/children6020033 · Cited by 115
Treating Painful Diabetic Peripheral Neuropathy: An Update.
Snyder, M. J., Gibbs, L. M., & Lindsay, T. J. (2016) · PubMed · Cited by 115
Hurley, R. W., Adams, M. C. B., Barad, M. J., Bhaskar, A., Bhatia, A., Chadwick, A. L., Deer, T. R., Hah, J. M., Hooten, W. M., Kissoon, N. R., et al. (2021) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2021-103031 · Cited by 115
Moyo, P., Simoni‐Wastila, L., Griffin, B. A., Onukwugha, E., Harrington, D., Alexander, G. C., & Palumbo, F. B. (2017) · Addiction · doi:10.1111/add.13860 · Cited by 114
Matthias, M. S., Johnson, N. L., Shields, C. G., Bair, M. J., MacKie, P., Huffman, M. A., & Alexander, S. C. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.06.008 · Cited by 116
Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis
Brady, J. E., Giglio, R. E., Keyes, K. M., DiMaggio, C. J., & Li, G. (2017) · Injury Epidemiology · doi:10.1186/s40621-017-0118-7 · Cited by 116
The Initiation of Chronic Opioids: A Survey of Chronic Pain Patients
Callinan, C. E., Neuman, M. D., Lacy, K. E., Gabison, C., & Ashburn, M. A. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.11.001 · Cited by 114
Quinn, P. D., Hur, K., Chang, Z., Krebs, E. E., Bair, M. J., Scott, E. L., Rickert, M. E., Gibbons, R. D., Kroenke, K., & D'Onofrio, B. M. (2016) · Pain · doi:10.1097/j.pain.0000000000000730 · Cited by 116
Patterns of Initial Opioid Prescribing to Opioid-Naive Patients
Larach, D. B., Waljee, J. F., Hu, H. M., Lee, J. S.-J., Nalliah, R. P., Englesbe, M. J., & Brummett, C. M. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002969 · Cited by 114
Bussières, A., Cancelliere, C., Ammendolia, C., Comer, C. M., Zoubi, F. A., Châtillon, C.-É., Chernish, G., Cox, J. M., Gliedt, J. A., Haskett, D., et al. (2021) · Journal of Pain · doi:10.1016/j.jpain.2021.03.147 · Cited by 119
James, J. R., Scott, J. M., Klein, J. W., Jackson, S. L., McKinney, C. M., Novack, M., Chew, L. D., & Merrill, J. O. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05301-2 · Cited by 115
Jeffery, M. M., Hooten, W. M., Hess, E. P., Meara, E. R., Ross, J. S., Henk, H. J., Borgundvaag, B., Shah, N. D., & Bellolio, F. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.08.042 · Cited by 112
Prevalence and incidence of prescription opioid analgesic use in Australia
Lalic, S., Ilomäki, J., Bell, J. S., Korhonen, M. J., & Gisev, N. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13792 · Cited by 110
Brief Mindfulness-Based Interventions for Acute and Chronic Pain: A Systematic Review
McClintock, A. S., McCarrick, S. M., Garland, E. L., Zeidan, F., & Zgierska, A. E. (2019) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0351 · Cited by 107
Schoenfeld, A. J., Jiang, W., Chaudhary, M. A., Scully, R. E., Koehlmoos, T. P., & Haider, A. H. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.2628 · Cited by 110
US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life
Enzinger, A. C., Ghosh, K., Keating, N. L., Cutler, D., Landrum, M. B., & Wright, A. A. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00476 · Cited by 112
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Callaghan, B. C., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s012 · Cited by 160
Chadwick, A. L., Hurley, R. W., & Benzon, H. T. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002426 · Cited by 110
America’s Opioid Epidemic: Supply and Demand Considerations
Clark, J. D., & Schumacher, M. A. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002388 · Cited by 113
Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing
Faul, M., Lurie, P. G., Kinsman, J. M., Dailey, M. W., Crabaugh, C., & Sasser, S. M. (2017) · Prehospital Emergency Care · doi:10.1080/10903127.2017.1315203 · Cited by 112
Kennedy, L. C., Binswanger, I. A., Mueller, S. R., Levy, C. R., Matlock, D. D., Calcaterra, S. L., Koester, S. K., & Frank, J. W. (2017) · Pain Medicine · doi:10.1093/pm/pnx276 · Cited by 110
Farrell, S., Green, A. L., & Aziz, T. Z. (2018) · Brain Sciences · doi:10.3390/brainsci8080158 · Cited by 108
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
Peckham, A. M., Evoy, K. E., Ochs, L. A., & Covvey, J. R. (2018) · Substance Abuse Research and Treatment · doi:10.1177/1178221818801311 · Cited by 114
Amirdelfan, K., Webster, L. R., Poree, L. R., Sukul, V., & McRoberts, P. (2017) · Spine · doi:10.1097/brs.0000000000002217 · Cited by 109
Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts
Rose, M. E. (2017) · Pain Medicine · doi:10.1093/pm/pnx048 · Cited by 110
Demidenko, M. I., Dobscha, S. K., Morasco, B. J., Meath, T. H. A., Ilgen, M. A., & Lovejoy, T. I. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.011 · Cited by 109
Risk Factors and Pooled Rate of Prolonged Opioid Use Following Trauma or Surgery
Mohamadi, A., Chan, J. J., Lian, J., Wright, C. L., Marin, A. M., Rodriguez, E. K., Keudell, A. G. V., & Nazarian, A. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.01239 · Cited by 108
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
Kripke, D. F. (2016) · F1000Research · doi:10.12688/f1000research.8729.1 · Cited by 106
The Surge of Opioid Use, Addiction, and Overdoses
Madras, B. K. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0163 · Cited by 113
Rethinking chronic pain in a primary care setting
Stanos, S. P., Brodsky, M., Argoff, C. E., Clauw, D. J., D’Arcy, Y. M., Donevan, S. D., Gebke, K. B., Jensen, M. P., Clark, E. L., McCarberg, B. H., et al. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1188319 · Cited by 107
2016 Update on Medical Overuse: A Systematic Review
Morgan, D. J., Dhruva, S. S., Wright, S. M., & Korenstein, D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5381 · Cited by 104
Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement
Rosen, I. M., Aurora, R. N., Kirsch, D. B., Carden, K. A., Malhotra, R. K., Ramar, K., Abbasi-Feinberg, F., Kristo, D. A., Martin, J. L., Olson, E. J., et al. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8062 · Cited by 111
Opioid use disorder and treatment: challenges and opportunities
Hoffman, K. A., Terashima, J. P., & McCarty, D. W. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4751-4 · Cited by 104
Association of Opioid Usage with Spinal Cord Stimulation Outcomes
Sharan, A. D., Riley, J. P., Falowski, S. M., Pope, J. E., Connolly, A. T., Karst, E., Dalal, N., & Provenzano, D. A. (2017) · Pain Medicine · doi:10.1093/pm/pnx262 · Cited by 103
Comparison of Opioid Prescribing by Dentists in the United States and England
Suda, K. J., Durkin, M. J., Calip, G. S., Gellad, W. F., Kim, H., Lockhart, P. B., Rowan, S. A., & Thornhill, M. H. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.4303 · Cited by 106
U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020
Boehnke, K. F., Dean, O., Haffajee, R. L., & Hosanagar, A. (2022) · Annals of Internal Medicine · doi:10.7326/m22-0217 · Cited by 109
“Lastly, poor outcomes with pain medications (16, 17), including opioids (18), have led some patients to seek alternatives (19).”
BackgroundThe Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
Manhapra, A., Arias, A. J., & Ballantyne, J. C. (2018) · Substance Abuse · doi:10.1080/08897077.2017.1381663 · Cited by 98
Cerdá, M., Gaidus, A. J., Keyes, K. M., Ponicki, W. R., Martins, S. S., Galea, S., & Gruenewald, P. J. (2016) · Addiction · doi:10.1111/add.13543 · Cited by 102
A case of U-47700 overdose with laboratory confirmation and metabolite identification
Jones, M., Hernandez, B. S., Janis, G. C., & Stellpflug, S. J. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1209767 · Cited by 103
Suicide Deaths With Opioid Poisoning in the United States: 1999–2014
Braden, J. B., Edlund, M. J., & Sullivan, M. D. (2017) · American Journal of Public Health · doi:10.2105/ajph.2016.303591 · Cited by 102
Promising roles for pharmacists in addressing the U.S. opioid crisis
Compton, W. M., Jones, C. M., Stein, J. B., & Wargo, E. M. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.12.009 · Cited by 106
Heapy, A. A., Higgins, D. M., Goulet, J. L., LaChappelle, K. M., Driscoll, M. A., Czlapinski, R. A., Buta, E., Piette, J. D., Krein, S. L., & Kerns, R. D. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.0223 · Cited by 101
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
Fischer, B., Rehm, J. T., & TYNDALL, M. W. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.160356 · Cited by 111
Opioid Use by Patients After Rhinoplasty
Patel, S. S., Sturm, A. K., Bobian, M. R., Svider, P. F., Zuliani, G. F., & Kridel, R. (2017) · JAMA Facial Plastic Surgery · doi:10.1001/jamafacial.2017.1034 · Cited by 101
Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases
Wiese, A. D., Griffin, M. R., Schaffner, W., Stein, C., Greevy, R. A., Mitchel, E. F., & Grijalva, C. G. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1907 · Cited by 102
Cook, D. J., Kaskovich, S., Pirkle, S., Mica, M. C., Shi, L. L., & Lee, M. J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.12.023 · Cited by 101
Metadata
- Authors
- Dowell, D., Haegerich, T. M., & Chou, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Dowell, Deborah
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-19
- Volume
- 315
- Issue
- 15
- Pages
- 1624
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6390846
- OpenAlex
- W2296986887
- Cited by
- 5,161
- References
- 215
- Citations by year
- 2026: 137 · 2025: 233 · 2024: 272 · 2023: 347 · 2022: 407 · 2021: 733 · 2020: 825 · 2019: 762 · 2018: 701 · 2017: 525 · 2016: 214
- FWCI
- 723.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Agency for Healthcare Research and Quality
- U.S. Public Health Service (200-2013-M-53890, 15IPA-1505478, 290201200014I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid prescribing, chronic pain, opioid use disorder, opioid overdose, benzodiazepines, prescription drug monitoring programs, buprenorphine, methadone, medication-assisted treatment, low-dose opioids, primary care
- MeSH terms
- Contraindications, Adult, Analgesics, Opioid, Benzodiazepines, Centers for Disease Control and Prevention, U.S., Communication, Drug Therapy, Combination, Goals, Humans, Drug Prescriptions, Primary Health Care, United States, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Chronic Pain, Acute Pain, Prescription Drug Misuse, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
